It is a healthcare private limited company based in New Delgi, Delhi, India, established in 2015.
2015 | New Delgi, Delhi, India | Struck OffGlobal Stemgenn Therapy & Research Private Limited, a struck off private limited company, was established on 17 March 2015 in New Delgi, Delhi, India. Engaging in other hospital and medical care activities within the hospital and medical care sector, it holds CIN: U74999DL2015PTC278022. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Its leadership includes Sharda Jain (Director), Yogesh Aggarwala (Additional Director). Past directors included Jyoti Agarwal, Prabhu Chandra Mishra, Rashmi Jain. Its latest AGM occurred on 29 September 2018, with the balance sheet filed on 31 March 2018. It is based at 11, Basement, Gagan Vihar, New Delgi, Delhi, 110051.
U74999DL2015PTC278022
278022
17 March 2015
₹0.10 M
₹0.10 M
Roc Delhi
Unlisted
Struck Off
Explore comprehensive insights into Global Stemgenn Therapy & Research Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sharda Jain | Director | 17 Mar 2015 | Current |
| Yogesh Aggarwala | Additional Director | 24 Mar 2015 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 24 Mar 2015 | Past |
| Pramod Abcsdd | Additional Director | 20 Mar 2019 | Past |
| Pramod Abcsdd | Additional Director | 20 Mar 2019 | Past |
| Pramod Abcsdd | Additional Director | 20 Mar 2019 | Past |
| Pramod Abcsdd | Additional Director | 20 Mar 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Global Stemgenn Therapy & Research Private Limited, for the financial year ended 2017, experienced significant reduction in revenue, with a 22.32% decrease. The company also saw a substantial improvement in profitability, with a 93.3% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth | |||||||
| EBITDA |
|
In 2017, Global Stemgenn Therapy & Research had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Global Stemgenn Therapy & Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Global Stemgenn Therapy & Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Global Stemgenn Therapy & Research's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Global Stemgenn Therapy & Research Private Limited last Annual general meeting of members was held on 29 Sep 2018 as per latest MCA records. was recorded as a recent event.
The activity Global Stemgenn Therapy & Research Private Limited has filed its annual Financial statements for the year ended 31 Mar 2018 with Roc Delhi. was completed.
Yogesh Aggarwala was appointed as a Additional Director was appointed as a Additional Director on 24 Mar 2015 & has been associated with this company since 10 years 8 months . was recorded as a recent event.
Sharda Jain was appointed as a Director was appointed as a Director on 17 Mar 2015 & has been associated with this company since 10 years 8 months . was recorded as a recent event.
Progress on Global Stemgenn Therapy & Research Private Limited was registered on 17 Mar 2015 with Roc Delhi & aged 10 years 8 months as per MCA records. was documented.
The CIN of Global Stemgenn Therapy & Research Private Limited is U74999DL2015PTC278022.
Global Stemgenn Therapy & Research Private Limited is headquartered at 11, Basement, Gagan Vihar, New Delgi, Delhi, 110051.
Global Stemgenn Therapy & Research Private Limited was incorporated on 17 March 2015.
The current directors of Global Stemgenn Therapy & Research Private Limited are
The primary industry of Global Stemgenn Therapy & Research Private Limited is Hospital And Medical Care.
Global Stemgenn Therapy & Research Private Limited is unlisted.
The authorized capital of Global Stemgenn Therapy & Research Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX